The other day I laid out the scenario that Momenta's typical 10% sales royalty IS equivalent to 45%/50% of Sandoz's profit. Then we have no reason to be concerned about a Teva generic approval because a 10% royalty is equal to 45-50% of profits. ;-) Jbog, that is clueless - DD already debunked that one. You sure have a way of bringing out my dark side. ij